Cervical Intraepithelial Neoplasia - 30 Studies Found
Terminated |
: Topical Imiquimod Versus Conization to Treat Cervical Intraepithelial Neoplasia : Cervical Intraepithelial Neoplasia : 2011-01-21 :
|
Terminated |
: Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) of Cervical Intraepithelial Neoplasia (CIN) Grade 1 : Cervical Intraepithelial Neoplasia : 2008-07-01 :
|
Completed |
: Efficacy and Safety Study of BLS_ILB_E710c for the Fertile Women With Cervical Intraepithelial Neoplasia(CIN3) : Cervical Intraepithelial Neoplasia : 2014-07-15 :
|
Completed |
: Efficacy and Safety Study of PGA (Poly-gamma Glutamic Acid) for Cervical Intraepithelial Neoplasia : Cervical Intraepithelial Neoplasia : 2013-03-29 :
|
Completed |
: A Study of RO5217790 in Participants With High Grade Cervical Intraepithelial Neoplasia (CIN) Associated With High Risk Human Papillomavirus (HR-HPV) Infection : Cervical Intraepithelial Neoplasia : 2009-11-20 :
|
Completed |
: A Pilot Study of EM-1421 for the Treatment of Cervical Intraepithelial Neoplasia : Cervical Intraepithelial Neoplasia : 2005-09-08 : Drug: EM-1421 EM-1421 administered intravaginally every 3 weeks as 45 mg (1% w/w) EM-1421 or 90 mg (2% w |
Completed |
: Management of Cervical Intraepithelial Neoplasia Grade 2 : Cervical Intraepithelial Neoplasia : 2008-08-07 :
|
Active, not recruiting |
: Dose-finding, Safety Study of Plasmid DNA Therapeutic Vaccine to Treat Cervical Intraepithelial Neoplasia : Cervical Intraepithelial Neoplasia : 2014-05-13 : Biological: GX-188E DNA vaccine administered via IM route using TDS-IM electroporation device |
Completed |
: ITIC (Imiquimod Therapy in Cervical Intraepithelial Neoplasia)-Trial : Cervical Intraepithelial Neoplasia : 2009-07-16 : Drug: Topical imiquimod therapy therapy consists of treatment with topical vaginal suppositories for 16 |
Recruiting |
: Effect of Curcumin in Treatment of Squamous Cervical Intraepithelial Neoplasias (CINs) : Cervical Intraepithelial Neoplasia : 2015-09-14 : Drug: Curcumin Patients will receive 500mg of curcumin administered orally, twice a day for 12 weeks. |